StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
49
Publishing Date
2023 - 08 - 09
1
2023 - 08 - 04
1
2023 - 07 - 31
1
2023 - 07 - 27
1
2023 - 07 - 11
1
2023 - 06 - 12
1
2023 - 05 - 31
1
2023 - 05 - 17
1
2023 - 05 - 01
1
2023 - 04 - 24
1
2023 - 04 - 20
1
2023 - 04 - 13
1
2023 - 03 - 27
1
2023 - 03 - 07
1
2023 - 02 - 27
1
2023 - 02 - 06
1
2023 - 02 - 01
1
2023 - 01 - 28
1
2023 - 01 - 06
1
2023 - 01 - 05
1
2022 - 12 - 22
1
2022 - 12 - 21
2
2022 - 12 - 15
1
2022 - 12 - 06
1
2022 - 12 - 01
1
2022 - 11 - 28
1
2022 - 11 - 21
1
2022 - 11 - 03
1
2022 - 10 - 28
1
2022 - 10 - 26
1
2022 - 10 - 18
1
2022 - 09 - 02
2
2022 - 08 - 30
1
2022 - 08 - 26
1
2022 - 08 - 03
2
2022 - 08 - 02
1
2022 - 07 - 28
1
2022 - 07 - 27
1
2022 - 06 - 14
1
2022 - 05 - 31
1
2022 - 05 - 18
1
2022 - 05 - 02
1
2022 - 04 - 20
1
2022 - 04 - 08
1
2022 - 04 - 07
1
2022 - 03 - 31
1
Sector
Commercial services
1
Communications
1
Construction
1
Electronic technology
3
Health technology
27
Industrial services
1
Manufacturing
5
Mining, quarrying, and oil and gas extraction
1
N/a
1
Non-energy minerals
1
Process industries
1
Professional, scientific, and technical services
1
Real estate and rental and leasing
1
Technology services
4
Tags
Acquisition
136
Agreement
127
Application
49
Biopharma
68
Business
110
Cancer
95
Ceo
72
Collaboration
54
Commercial
48
Conference
628
Corporation
120
Day
59
Deadline
211
Disease
87
Drug
63
Earnings
164
Energy
155
Events
157
Fda
94
Financial
549
Genetown
56
Global
213
Group
141
Growth
176
Health
124
International
86
Life
48
Management
68
Market
314
Media
50
Medical
48
Meeting
117
N/a
6257
Nasdaq
83
Offering
80
Partnership
63
People
62
Pharm-country
58
Pharma
81
Pharmaceuticals
114
Phase 2
51
Platform
68
Positive
100
Potential
55
Presentation
74
Program
130
Report
348
Research
237
Results
1028
Sciences
54
Services
89
Solutions
91
Study
102
System
68
Technology
136
Therapeutics
411
Treatment
128
Trial
175
Update
213
Year
223
Entities
36kr holdings inc.
1
Acer therapeutics inc.
1
Advanced micro devices, inc.
1
Aldeyra therapeutics, inc.
1
Apple inc.
1
Ardelyx, inc.
1
Astria therapeutics, inc.
1
Au optronics corp
1
Axsome therapeutics, inc.
1
Bactech environmental corp
1
Bausch health companies inc.
1
Biocardia, inc.
1
Biogen inc.
1
Broadcom inc.
1
Bynd cannasoft enterprises inc
1
Casi pharmaceuticals, inc.
2
Clean energy technologies, inc.
1
Cognizant technology solutions corporation
1
Corning incorporated
1
Creative medical technology holdings, inc.
1
Cybin inc
1
Delcath systems, inc.
1
Dynatrace, inc.
1
Enlivex therapeutics ltd.
1
Femasys inc
1
Genmab a/s
1
Gold royalty corp
1
Goldmining inc.
1
Immuneering corp class a
1
Inhibikase therapeutics, inc.
1
Innospec inc.
1
Intel corporation
1
Ionis pharmaceuticals, inc.
1
Jaguar health, inc.
1
Koninklijke philips n.v.
1
Lexicon pharmaceuticals, inc.
1
Mediwound ltd.
1
Microchip technology incorporated
1
Neuroone medical technologies corp
1
Nvidia corporation
1
Ocean biomedical inc
2
Orange
1
Orchard therapeutics plc
2
Outlook therapeutics, inc.
5
Ptc inc.
1
Sage therapeutics, inc.
1
Salarius pharmaceuticals, inc.
1
Sarepta therapeutics, inc.
1
Tenax therapeutics, inc.
1
Texas instruments incorporated
1
Unicycive therapeutics inc
1
United health products, inc.
1
Vericel corporation
1
Symbols
AAPL
1
ACER
1
ALDX
1
AMD
1
ARDX
1
ATXS
1
AUOTY
1
AVGO
1
AXSM
1
BCAN
1
BCCEF
1
BCDA
1
BHC
1
BIIB
1
CASI
2
CELZ
1
CETY
1
CTSH
1
CYBN
1
DCTH
1
DT
1
ENLV
1
FEMY
1
FNCTF
1
GLDG
1
GLW
1
GMAB
1
GNMSF
1
GROY
1
IKT
1
IMRX
1
INTC
1
IONS
1
IOSP
1
JAGX
1
KRKR
1
LXRX
1
MCHP
1
MDWD
1
NMTC
1
NVDA
1
OCEA
2
ORTX
2
OTLK
5
PHG
1
PTC
1
SAGE
1
SLRX
1
SRPT
1
TENX
1
TXN
1
UEEC
1
UNCY
1
VCEL
1
Exchanges
Amex
1
Nasdaq
45
Nyse
5
Crawled Date
2023 - 08 - 09
1
2023 - 08 - 04
1
2023 - 07 - 31
1
2023 - 07 - 27
1
2023 - 07 - 11
1
2023 - 06 - 12
1
2023 - 05 - 31
1
2023 - 05 - 17
1
2023 - 05 - 01
1
2023 - 04 - 24
1
2023 - 04 - 20
1
2023 - 04 - 13
1
2023 - 03 - 27
1
2023 - 03 - 07
1
2023 - 02 - 27
1
2023 - 02 - 06
1
2023 - 02 - 01
1
2023 - 01 - 28
1
2023 - 01 - 06
1
2023 - 01 - 05
1
2022 - 12 - 22
1
2022 - 12 - 21
2
2022 - 12 - 15
1
2022 - 12 - 06
1
2022 - 12 - 01
1
2022 - 11 - 28
1
2022 - 11 - 21
1
2022 - 11 - 03
1
2022 - 10 - 28
1
2022 - 10 - 26
1
2022 - 10 - 18
1
2022 - 09 - 02
2
2022 - 08 - 30
1
2022 - 08 - 26
1
2022 - 08 - 03
2
2022 - 08 - 02
1
2022 - 07 - 28
1
2022 - 07 - 27
1
2022 - 06 - 14
1
2022 - 05 - 31
1
2022 - 05 - 18
1
2022 - 05 - 02
1
2022 - 04 - 20
1
2022 - 04 - 08
1
2022 - 04 - 07
1
2022 - 03 - 31
1
Crawled Time
00:00
46
00:02
1
00:20
9
01:00
37
02:00
17
03:00
22
04:00
15
04:20
9
05:00
17
05:04
1
06:00
29
07:00
41
08:00
42
08:02
1
08:05
1
08:20
2
09:00
43
10:00
32
11:00
130
11:01
2
12:00
255
12:01
6
12:03
8
12:07
2
12:15
31
12:20
49
12:30
64
13:00
228
13:01
8
13:03
5
13:04
3
13:15
24
13:20
49
13:30
55
13:35
3
14:00
180
14:01
4
14:04
4
14:15
15
14:20
19
14:30
26
15:00
108
15:15
18
15:20
13
15:30
32
16:00
54
16:04
2
16:20
2
17:00
102
18:00
74
19:00
83
20:00
75
20:20
2
21:00
91
21:03
2
22:00
74
22:02
2
22:12
3
22:15
4
23:00
60
Source
jaguarhealth.gcs-web.com
1
spacfeed.com
1
www.bactechgreen.com
1
www.biospace.com
12
www.globenewswire.com
21
www.prnewswire.com
13
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Application
crawled time :
12:20
save search
Napo Pharmaceuticals, a Jaguar Health Family Company, Submits Funding Application to BARDA for Development of NP-300 Drug Candidate for Cholera-Related Diarrhea
Published:
2023-08-09
(Crawled : 12:20)
- jaguarhealth.gcs-web.com
JAGX
|
$0.1637
-8.19%
-8.92%
130M
|
Health Technology
|
-70.27%
|
O:
0.85%
H:
0.84%
C:
-10.4%
np-300
drug
candidate
diarrhea
health
application
family
funding
United Health Products Reports on Product Testing for FDA Application
Published:
2023-08-04
(Crawled : 12:20)
- globenewswire.com
UEEC
|
$0.19
7.9%
26K
|
Manufacturing
|
-41.81%
|
O:
-5.05%
H:
1.68%
C:
-3.23%
fda
health
application
Israeli Technology Company BYND Cannasoft Enterprises Files US Provisional Patent Application and Full Scale PCT Application for Its EZ-G Device
Published:
2023-07-31
(Crawled : 12:20)
- globenewswire.com
BCAN
|
$1.13
28.86%
22.4%
8.2M
|
Construction
|
-32.02%
|
O:
1.56%
H:
3.05%
C:
-0.76%
patent
device
application
technology
Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemBloc for Female Permanent Birth Control
Published:
2023-07-27
(Crawled : 12:20)
- globenewswire.com
FEMY
|
$1.295
-1.15%
-1.16%
120K
|
Manufacturing
|
259.89%
|
O:
62.09%
H:
77.97%
C:
42.37%
patent
control
application
Salarius Pharmaceuticals Receives FDA Clearance of SP-3164 Investigational New Drug Application to Begin a Phase 1 Clinical Trial in Relapsed/Refractory Non-Hodgkin Lymphoma Patients
Published:
2023-07-11
(Crawled : 12:20)
- globenewswire.com
SLRX
A
|
$0.486
-2.8%
-2.88%
110K
|
Commercial Services
|
-65.52%
|
O:
3.45%
H:
0.01%
C:
-15.33%
sp-3164
fda
drug
clearance
pharmaceuticals
application
trial
NeuroOne® Submits 510(k) Application to FDA for OneRF™ Ablation System
Published:
2023-06-12
(Crawled : 12:20)
- globenewswire.com
NMTC
|
$1.15
0.88%
46K
|
Real Estate and Rental and Leas...
|
-6.5%
|
O:
13.01%
H:
0.72%
C:
-5.76%
neuroone
fda
application
Tenax Therapeutics Achieves Major Milestone as USPTO Grants Notice of Allowance for U.S. Patent Application Covering Use of Oral Levosimendan (TNX-103) in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
Published:
2023-05-31
(Crawled : 12:20)
- globenewswire.com
TENX
|
$3.59
-0.55%
-0.84%
26K
|
Health Technology
|
1028.13%
|
O:
12.66%
H:
22.05%
C:
0.58%
tnx-103
patent
levosimendan
hypertension
heart
application
grants
therapeutics
milestone
Ardelyx Announces FDA Acceptance and Six-Month Review for Resubmission of its New Drug Application of XPHOZAH® (tenapanor)User Fee Goal Date: October 17, 2023
Published:
2023-05-17
(Crawled : 12:20)
- biospace.com/
ARDX
|
$6.56
-2.24%
-2.29%
3.6M
|
Health Technology
|
50.45%
|
O:
-6.5%
H:
1.11%
C:
-5.76%
xphozah
fda
drug
resubmission
review
application
Ortho Dermatologics Announces U.S. Food and Drug Administration New Drug Application Filing Acceptance for Investigational Acne Treatment IDP-126 Gel
Published:
2023-05-01
(Crawled : 12:20)
- biospace.com/
BHC
|
$8.66
-0.92%
0.0%
2.2M
|
Health Technology
|
18.59%
|
O:
0.14%
H:
3.66%
C:
1.76%
idp-126
drug
food
treatment
gel
application
acne
36Kr Pioneers the Application of AI Technology in Opening an E-Commerce Store and Leveraging AI to Explore Diversified Monetization Avenues
Published:
2023-04-24
(Crawled : 12:20)
- prnewswire.com
KRKR
|
$0.3721
-0.86%
4.7K
|
Technology Services
|
-62.6%
|
O:
-0.49%
H:
0.0%
C:
-1.51%
application
technology
store
Ocean Biomedical (NASDAQ: OCEA) Announces Notice of Allowance for U.S. Patent Application for Breakthrough Pulmonary Fibrosis Treatments Issued to Scientific Co-founder Dr. Jack A. Elias.
Published:
2023-04-20
(Crawled : 12:20)
- globenewswire.com
OCEA
|
$1.78
-0.56%
-0.56%
160K
|
|
-72.8%
|
O:
7.6%
H:
11.58%
C:
1.69%
patent
fibrosis
jack
application
Ocean Biomedical (NASDAQ: OCEA) Announces Notice of Allowance for U.S. Patent Application for Developing “Whole New Class” of Malaria Therapeutics Issued to Scientific Co-founder Dr. Jonathan Kurtis
Published:
2023-04-13
(Crawled : 12:20)
- globenewswire.com
OCEA
|
$1.78
-0.56%
-0.56%
160K
|
|
-60.31%
|
O:
10.2%
H:
49.09%
C:
36.02%
patent
malaria
application
therapeutics
Delcath Systems, Inc. Announces FDA Acceptance of New Drug Application Resubmission of Hepzato Kit with a PDUFA Date of August 14, 2023
Published:
2023-03-27
(Crawled : 12:20)
- prnewswire.com
DCTH
|
$4.49
-5.07%
-5.35%
200K
|
Health Technology
|
-2.27%
|
O:
18.8%
H:
9.04%
C:
4.35%
fda
drug
resubmission
pdufa
application
hepzato
Ionis announces FDA acceptance of New Drug Application for eplontersen for the treatment of hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN)
Published:
2023-03-07
(Crawled : 12:20)
- prnewswire.com
IONS
|
$40.93
-1.47%
-1.49%
1.1M
|
Health Technology
|
14.59%
|
O:
0.66%
H:
0.0%
C:
-2.27%
treatment
fda
drug
application
eplontersen
GoldMining Announces Launch of U.S. GoldMining IPO and Application to List on the NYSE American
Published:
2023-02-27
(Crawled : 12:20)
- prnewswire.com
GROY
|
$1.93
0.0%
560K
|
Mining, Quarrying, and Oil and ...
|
-9.81%
|
O:
0.93%
H:
2.55%
C:
-0.93%
GLDG
|
$0.8319
-2.92%
0.0%
370K
|
Non-Energy Minerals
|
-11.66%
|
O:
3.09%
H:
5.0%
C:
3.0%
application
Sage Therapeutics and Biogen Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression
Published:
2023-02-06
(Crawled : 12:20)
- biospace.com/
SAGE
|
$12.585
-19.48%
-24.2%
4.3M
|
Health Technology
|
-64.61%
|
O:
0.27%
H:
6.75%
C:
3.25%
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
-31.2%
|
O:
0.51%
H:
2.52%
C:
1.12%
treatment
fda
drug
application
grants
therapeutics
review
depression
major depressive disorder
NRC Begins Public Engagement for TRISO-X Advanced Nuclear Fuel Facility License Application – Marketscreener.com
Published:
2023-02-01
(Crawled : 12:20)
- spacfeed.com
CETY
|
$1.47
-9.82%
-10.88%
93K
|
Manufacturing
|
Email alert
Add to watchlist
application
nuclear
license
Flexible Display Global Market Report 2022: by Display Type, Substrate Material, Form Factor, Application and Region
Published:
2023-01-28
(Crawled : 12:20)
- prnewswire.com
AUOTY
|
$5.45
1.75%
99K
|
Manufacturing
|
Email alert
Add to watchlist
GLW
|
$30.98
0.19%
0.0%
5.2M
|
Electronic Technology
|
Email alert
Add to watchlist
PHG
|
$20.15
-0.89%
0.0%
790K
|
Health Technology
|
Email alert
Add to watchlist
global
report
application
market
CASI PHARMACEUTICALS AND CLEAVE THERAPEUTICS ANNOUNCE CLINICAL TRIAL APPLICATION APPROVAL FOR CB-5339 IN PATIENTS WITH MULTIPLE MYELOMA IN CHINA
Published:
2023-01-06
(Crawled : 12:20)
- prnewswire.com
CASI
|
$2.21
-5.56%
-5.88%
41K
|
Health Technology
|
17.0%
|
O:
3.0%
H:
4.85%
C:
-2.43%
cb-5339
pharmaceuticals
application
trial
approval
therapeutics
china
Orchard Therapeutics Announces U.S. FDA Clearance of IND Application for OTL-203 in MPS-IH
Published:
2023-01-05
(Crawled : 12:20)
- globenewswire.com
ORTX
|
$16.7
0.0%
370K
|
Health Technology
|
222.91%
|
O:
33.65%
H:
4.61%
C:
-8.47%
otl-203
fda
clearance
application
therapeutics
mps-ih
mps-i
← Previous
1
2
3
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.